In the BioHarmony Drug Report Database
Cefprozil
Cefzil (cefprozil) is a small molecule pharmaceutical. Cefprozil was first approved as Cefzil on 1991-12-23. It is used to treat bacterial infections, bacterial skin diseases, bronchitis, escherichia coli infections, and haemophilus infections amongst others in the USA.
Trade Name
|
Cefzil |
|---|---|
Common Name
|
cefprozil |
ChEMBL ID
|
CHEMBL3184906 |
Indication
|
bacterial infections, bacterial skin diseases, bronchitis, escherichia coli infections, haemophilus infections, klebsiella infections, moraxellaceae infections, otitis media, pharyngitis, proteus infections, sinusitis, staphylococcal infections, streptococcal infections |
Drug Class
|
Cephalosporins |
Image (chem structure or protein)